These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Felbamate: successful development of a new compound for the treatment of epilepsy. Schmidt D Epilepsia; 1993; 34 Suppl 7():S30-3. PubMed ID: 8243376 [TBL] [Abstract][Full Text] [Related]
12. Tolerability and pharmacokinetics of monotherapy felbamate doses of 1,200-6,000 mg/day in subjects with epilepsy. Sachdeo R; Narang-Sachdeo SK; Shumaker RC; Perhach JL; Lyness WH; Rosenberg A Epilepsia; 1997 Aug; 38(8):887-92. PubMed ID: 9579889 [TBL] [Abstract][Full Text] [Related]
13. Felbamate in an adult population with severe refractory epilepsy. Kearney H; Delanty N Ir Med J; 2009; 102(10):326-8. PubMed ID: 20108801 [TBL] [Abstract][Full Text] [Related]
14. Evaluation of case reports of aplastic anemia among patients treated with felbamate. Kaufman DW; Kelly JP; Anderson T; Harmon DC; Shapiro S Epilepsia; 1997 Dec; 38(12):1265-9. PubMed ID: 9578520 [TBL] [Abstract][Full Text] [Related]
15. Anticonvulsant activity of felbamate in amygdala kindling model of temporal lobe epilepsy in rats. Wlaź P; Löscher W Epilepsia; 1997 Nov; 38(11):1167-72. PubMed ID: 9579916 [TBL] [Abstract][Full Text] [Related]